{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:24:25Z","timestamp":1788456265493,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chung-Ang University Research Grant in 2023","award":["20230027"],"award-info":[{"award-number":["20230027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polypharmacy is a global public health concern. This study aimed to determine the prevalence of polypharmacy and trends in the use of commonly used and potentially inappropriate medications among older Korean patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Individuals aged\u2009\u2265\u200965 years who were prescribed any medication between 2014 and 2018 were selected from the Korean National Health Information Database. Joinpoint regression analyses were used to determine trends in the age-adjusted polypharmacy rates by age group. The prescription rates of the most commonly used medications and the most commonly used potentially inappropriate medications were analysed by year or age group for patients with polypharmacy using the chi-square and proportion difference tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study included 1,849,968 patients, 661,206 (35.7%) of whom had polypharmacy. Age-adjusted polypharmacy rates increased significantly between 2014 and 2018 (<jats:italic>P<\/jats:italic>\u2009=\u20090.046). Among patients with polypharmacy, the most commonly prescribed medications were aspirin (100\u00a0mg), atorvastatin, metformin, glimepiride, and rosuvastatin. The most commonly prescribed and potentially inappropriate medications were alprazolam, diazepam, amitriptyline, zolpidem, and dimenhydrinate. There was a significant decrease in the prescription rates for each of these drugs in 2018 compared with 2014 among patients with polypharmacy (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), whereas there was a significant increase in alprazolam prescription among patients aged\u2009\u2265\u200985 years when analysed by age group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study revealed an increasing prevalence of polypharmacy among older adults. Additionally, it highlighted that the utilisation of commonly prescribed potentially inappropriate medications, such as benzodiazepines and tricyclic antidepressants, has remained persistent, particularly among patients aged\u2009\u2265\u200985 years who practiced polypharmacy. These findings provide evidence-based guidance for the development of robust polypharmacy management strategies to ensure medication safety among older adults.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-024-05141-8","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:02:46Z","timestamp":1718985766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trends in commonly used and potentially inappropriate medications in older Korean patients with polypharmacy"],"prefix":"10.1186","volume":"24","author":[{"given":"Woo-young","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hwa","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"5141_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3399\/bjgp11X556146","volume":"61","author":"RA Payne","year":"2011","unstructured":"Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract. 2011;61:83\u20134. https:\/\/doi.org\/10.3399\/bjgp11X556146","journal-title":"Br J Gen Pract"},{"key":"5141_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr"},{"key":"5141_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175:827\u201334. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0324","journal-title":"JAMA Intern Med"},{"key":"5141_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57\u201365. https:\/\/doi.org\/10.1517\/14740338.2013.827660","journal-title":"Expert Opin Drug Saf"},{"key":"5141_CR5","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.21037\/atm-21-4238","volume":"9","author":"F Tian","year":"2021","unstructured":"Tian F, Liao S, Chen Z, Xu T. The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study. Ann Transl Med. 2021;9:1483. https:\/\/doi.org\/10.21037\/atm-21-4238","journal-title":"Ann Transl Med"},{"key":"5141_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00520-020-05529-3","volume":"29","author":"MR Keats","year":"2021","unstructured":"Keats MR, Cui Y, DeClercq V, Grandy SA, Sweeney E, Dummer TJB. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study. Support Care Cancer. 2021;29:713\u201323. https:\/\/doi.org\/10.1007\/s00520-020-05529-3","journal-title":"Support Care Cancer"},{"key":"5141_CR7","unstructured":"Porter RS, Kaplan JL. Merck manual of diagnosis and therapy. 19th edition. Merck Sharp and Dohme Corp.: Whitehouse Station, NJ; 2011."},{"key":"5141_CR8","volume-title":"WHO Global patient safety challenge: medication without harm","author":"WHO","year":"2017","unstructured":"WHO. WHO Global patient safety challenge: medication without harm. Geneva: World Health Organization; 2017."},{"key":"5141_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5414\/CP202484","volume":"54","author":"HY Park","year":"2016","unstructured":"Park HY, Ryu HN, Shim MK, Sohn HS, Kwon JW. Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on national health insurance claims data. Int J Clin Pharmacol Ther. 2016;54:369\u201377. https:\/\/doi.org\/10.5414\/CP202484","journal-title":"Int J Clin Pharmacol Ther"},{"key":"5141_CR10","unstructured":"Jang T. A study on the drug prescription status, underlying disease, and prognosis of polypharmacy users using data from the National Health Insurance. National Health Insurance Service Ilsan Hospital. LaB; 2019."},{"key":"5141_CR11","doi-asserted-by":"publisher","first-page":"866318","DOI":"10.3389\/fphar.2022.866318","volume":"13","author":"HJ Cho","year":"2022","unstructured":"Cho HJ, Chae J, Yoon SH, Kim DS. Aging and the prevalence of polypharmacy and hyper-polypharmacy among older adults in South Korea: a national retrospective study during 2010\u20132019. Front Pharmacol. 2022;13:866318. https:\/\/doi.org\/10.3389\/fphar.2022.866318","journal-title":"Front Pharmacol"},{"key":"5141_CR12","doi-asserted-by":"publisher","first-page":"e2326910","DOI":"10.1001\/jamanetworkopen.2023.26910","volume":"6","author":"F Tian","year":"2023","unstructured":"Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis. JAMA Netw Open. 2023;6:e2326910. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26910","journal-title":"JAMA Netw Open"},{"key":"5141_CR13","doi-asserted-by":"publisher","first-page":"e34818","DOI":"10.1097\/MD.0000000000034818","volume":"102","author":"JY Dong","year":"2023","unstructured":"Dong JY, Ju JH, Yang YM. Analysis of the prescription trends of potentially inappropriate medications in Korean older outpatients by sex: a retrospective study using data from the health insurance review and assessment service. Med (Baltim). 2023;102:e34818. https:\/\/doi.org\/10.1097\/MD.0000000000034818","journal-title":"Med (Baltim)"},{"key":"5141_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12877-016-0285-3","volume":"16","author":"YS Nam","year":"2016","unstructured":"Nam YS, Han JS, Kim JY, Bae WK, Lee K. Prescription of potentially inappropriate medication in Korean older adults based on 2012 beers criteria: a cross-sectional population based study. BMC Geriatr. 2016;16:118. https:\/\/doi.org\/10.1186\/s12877-016-0285-3","journal-title":"BMC Geriatr"},{"key":"5141_CR15","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","unstructured":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227\u201346. https:\/\/doi.org\/10.1111\/jgs.13702","journal-title":"J Am Geriatr Soc"},{"key":"5141_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12877-023-04165-w","volume":"23","author":"HW Chae","year":"2023","unstructured":"Chae HW, Zhao J, Ah YM, Choi KH, Lee JY. Potentially inappropriate medication use as predictors of hospitalization for residents in nursing home. BMC Geriatr. 2023;23:467. https:\/\/doi.org\/10.1186\/s12877-023-04165-w","journal-title":"BMC Geriatr"},{"key":"5141_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15656\/kjcg.2021.22.2.55","volume":"22","author":"W Shin","year":"2021","unstructured":"Shin W, Song JS, Kim J. Polypharmacy management program: current status and emerging challenges in older patients. Korean J Geriatr Gerontol. 2021;22:55\u201360. https:\/\/doi.org\/10.15656\/kjcg.2021.22.2.55","journal-title":"Korean J Geriatr Gerontol"},{"key":"5141_CR18","doi-asserted-by":"publisher","DOI":"10.4097\/kja.20129","author":"E Ahn","year":"2020","unstructured":"Ahn E. Introducing big data analysis using data from National Health Insurance Service. Korean J Anesthesiol. 2020;73:205\u201311. https:\/\/doi.org\/10.4097\/kja.20129"},{"key":"5141_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46:799\u2013800. https:\/\/doi.org\/10.1093\/ije\/dyw253","journal-title":"Int J Epidemiol"},{"key":"5141_CR20","unstructured":"Korean Statistical Information Service. Population trend survey 1993\u20132022. Daejeon: Statistics Korea. 2023. https:\/\/kosis.kr\/statHtml\/statHtml.do?orgId=101&tblId=DT_1B040M5. Accessed 03 Jan 2024."},{"key":"5141_CR21","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71:2052\u201381. https:\/\/doi.org\/10.1111\/jgs.18372","journal-title":"J Am Geriatr Soc"},{"key":"5141_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 updated AGS beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674\u201394. https:\/\/doi.org\/10.1111\/jgs.15767","journal-title":"J Am Geriatr Soc"},{"key":"5141_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s11096-020-00980-y","volume":"42","author":"Y Huang","year":"2020","unstructured":"Huang Y, Zhang L, Huang X, Liu K, Yu Y, Xiao J. Potentially inappropriate medications in Chinese community-dwelling older adults. Int J Clin Pharm. 2020;42:598\u2013603. https:\/\/doi.org\/10.1007\/s11096-020-00980-y","journal-title":"Int J Clin Pharm"},{"key":"5141_CR24","doi-asserted-by":"publisher","unstructured":"Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine use in older adults: dangers, management, and alternative therapies. Mayo Clin Proc. 2016;91:1632-9. https:\/\/doi.org\/10.1016\/j.mayocp.2016.07.024","DOI":"10.1016\/j.mayocp.2016.07.024"},{"key":"5141_CR25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3904\/kjim.2021.457","volume":"37","author":"JY Choi","year":"2022","unstructured":"Choi JY, Kim H, Jung YI, Chun S, Yoo S, Lim JY, et al. Factors associated with anticholinergic burden among older patients in long-term care hospitals in Korea. Korean J Intern Med. 2022;37:468\u201377. https:\/\/doi.org\/10.3904\/kjim.2021.457","journal-title":"Korean J Intern Med"},{"issue":"1","key":"5141_CR26","doi-asserted-by":"publisher","first-page":"18073","DOI":"10.1038\/s41598-022-23032-z","volume":"12","author":"WY Shin","year":"2022","unstructured":"Shin WY, Go TH, Kang DR, Lee SY, Lee W, Kim S, Lee J, Kim JH. Patterns of patients with polypharmacy in adult population from Korea. Sci Rep. 2022;12(1):18073. https:\/\/doi.org\/10.1038\/s41598-022-23032-z","journal-title":"Sci Rep"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05141-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05141-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05141-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:03:24Z","timestamp":1718985804000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05141-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5141"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05141-8","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Given the specific nature of the NHID, the requirement for written informed consent was waived by the Institutional Review Board of Chung-ang University Medical Center, Republic of Korea. Ethical approval for this study was granted by the Institutional Review Board of Chung-ang University Medical Center (2003-010-19308).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"542"}}